After almost two years on the auction block, Novartis' ($NVS) manufacturing facility in Suffern, NY, is likely to be sold by the end of this winter as two developers...

ScHARR completes independent, scientific, peer reviewed study, funded by Exco InTouch, comparing EQ-5D-5L equivalence across mobile phone and paper administration mod...